v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 502,090 $ 218,028
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 75,830 54,526
Amortization of debt issuance costs and non-cash interest 618 633
Gain on disposal of property and equipment (1,795) (2,500)
Changes in the fair value of earn-outs 7,463 4,029
Loss on extinguishment of debt 1,265 0
Distribution of earnings from unconsolidated subsidiaries 17,332 16,252
Equity in earnings from unconsolidated subsidiaries (10,536) (11,082)
Deferred taxes 11,766 9,256
Stock-based compensation 26,796 18,241
Changes in operating assets and liabilities (Note 15) (203,734) (53,446)
Net cash provided by operating activities 427,095 253,937
Cash flows from investing activities:    
Acquisitions, net of cash acquired (164,995) (484,156)
Capital expenditures (115,458) (50,923)
Proceeds from sale of property and equipment 4,202 4,014
Net cash used in investing activities (276,251) (531,065)
Cash flows from financing activities:    
Borrowings under the revolving credit facility 160,000 0
Repayments of the revolving credit facility (65,000) 0
Repayments of term loan and other financing agreements (296,444) (21,067)
Distributions to noncontrolling interest owners (980) 0
Capital contributions from noncontrolling interest owners 14,700 0
Repurchase of common stock (107,262) (48,546)
Withholding taxes paid on net share settlement of equity awards (15,991) (9,650)
Payments of earn-outs (7,767) 0
Debt issuance costs (5,884) (1,409)
Net cash used in financing activities (324,628) (80,672)
Net change in cash, cash equivalents, and restricted cash (173,784) (357,800)
Cash, cash equivalents and restricted cash at beginning of period 390,721 664,195
Cash, cash equivalents and restricted cash at end of period 216,937 306,395
Less: restricted cash 0 0
Cash and cash equivalents at end of period 216,937 306,395
Non-cash items:    
Accrued capital expenditures 5,718 4,297
Share consideration for acquisitions 27,406 79,458
Insurance premiums financed through short-term financing agreement $ 10,646 $ 0